We’re presenting our phase 3 CAN-2409 localized prostate cancer trial at #ASTRO2025, with a subanalysis focused on type of radiation therapy used in the trial. https://t.co/k1c7Tq7UlJ #ProstateCancer #ClinicalData #RadiationOncology

We will be presenting lorundrostat data from our Phase 2 Explore-CKD trial in a late-breaking session next month at @ASNKidney #KidneyWk on Friday, November 7. Read our press release for additional details: https://t.co/cWSIQ3ejFl #Hypertension #CKD #ClinicalData $MLYS

LATE-BREAKING #ClinicalData: FARADISE registry highlights the safety and effectiveness of the FARAPULSE™ #PFA system in over 1,100 patients. - 1.5% primary adverse event rate - 80.8% 12-month clinical effectiveness in paroxysmal AF #ESCCongress

Join us at BiotechX Europe to see how a single semantic layer can reshape clinical data integration. #HealthcareAI #OMOP #ClinicalData #LLM #GenerativeAI #DigitalHealth #JohnSnowLabs

1.“When precision meets expertise — https://t.co/jfj2iJjxUv brings diagnosis to data. #HealthTech #MedicalAI #DataAnalysis #HealthcareInnovation” 2.“Smart analytics for smarter medicine — discover https://t.co/jfj2iJjxUv. #MedTech #AIinHealthcare #ClinicalData #HealthInsights”

The #RevvitySignals team can’t wait for #OCTSanDiego! If you're attending, stop by Booth 39. We'd loved to share how Signals Clinical, our end-to-end #clinicaldata science platform, is transforming trials with higher-quality data and faster reviews. Excited to connect!

Good data is powerful—but turning it into action drives revenue & quality. See how @Nordic_Global helped Monument Health transform CDI: https://t.co/eVuXW9mTee #RevCycle #ClinicalData #Innovation #healthIT #healthcare

Consistent, explainable, and safe. Dia Trambitas shows how @JohnSnowLabs automates PHI removal at scale. Don’t miss this one: https://t.co/nCgZUG8oI7 #AIethics #ClinicalData

#VNS Retinal organoids restore sight in lab trials; refining implants and clinical data is the next step.👁️‍🗨️🔬 @CooperVision @TJU1895 #clinicaldata #coopervision #restoresight Details: https://t.co/WzdSF68lfk

Cedars-Sinai’s New PhD in Health AI Program Earns Accreditation https://t.co/9MOxPIc6Ka @CedarsSinai #AIResearch #clinicalrotations #clinicaldata #academictraining #accreditation #HealthSciencesUniversity

🧠 PFA Key Topics – Capsule 2: Coronary Artery Effects Now on EDUCARE: https://t.co/jUjN2rDpdr Explore how #PFA may impact coronary structure and function: ✔️ Acute spasm mechanisms ✔️ Long-term vascular effects ✔️ Latest #ClinicalData & mitigation strategies

PFA Key Topics — a new series of concise, expert-led capsules exploring the science behind #PFA 📍Capsule 1: Haemolysis in PFA 🔹 Why it happens 🔹 Biomarkers to track 🔹 Workflow-related risks 🔹 Latest #ClinicalData 📎Watch: https://t.co/R73Y4ATpD7 #MedEd

Submitting #clinicaldata to both the #FDA and #PMDA can be complex. Our whitepaper shows how to simplify the process and reduce duplication. Read the whitepaper for expert insights: https://t.co/MtLrfzytVE

That’s a wrap!  A huge thank you to all participants for showcasing bold #AgenticAI ideas, and to our judges for their guidance in shaping the future of #clinicaltrials.  #hackathon #clinicaldata #healthcare

📊New #ClinicalData could sway your opinion on mechanical heart valves in younger patients. Join our #AATS2025 symposium to hear an expert panel assess the evidence and its impact. 🗓️ Save the info: https://t.co/3fJcAttCNH Important Safety Info: https://t.co/WEC893RGNE

Vitruvian Partners Buys Majority Stake in DeepIntent  The transaction will fund DeepIntent’s next stage of expansion, including the integration of generative AI and real-world clinical data. #AI #Artificialintelligence #Clinicaldata #DSPs https://t.co/WePaYafswm

We’re looking forward to connecting at BiotechX@BioTechX_ Europe 2025 this October in Basel. 📅 October 6th | 12:05 PM Talk: LLM-Orchestrated Integration of Multimodal Clinical Data into a Unified OMOP Model #HealthcareAI #OMOP #ClinicalData #LLM #GenerativeAI #DigitalHealth

$LXRX - Lexicon Pharmaceuticals drops 🔥 NEW data to the FDA proving Zynquista® might actually shift the game in Type 1 Diabetes treatment. The benefit-risk debate just got real 😏 #LXRX #Zynquista #Type1Diabetes #DiabetesResearch #PharmaNews #FDA #ClinicalData

The clinical program behind the CADScor®System is comprehensive, with the Adopt CAD, BIO-CAC and Dan-NICAD clinical studies. Click here to learn more! #Acarix #CADScorSystem #coronaryarterydisease #CAD #chestpain #clinicaldata https://t.co/lfcbNHzFJk